Key result
A review of available medical evidence indicates that the recent development of drug-eluting stents is a step toward overcoming restenosis in the treatment of coronary artery disease.
Why the study?
Do drug-eluting stents overcome restenosis in patients with coronary artery disease?
Do drug-eluting stents overcome restenosis in patients with coronary artery disease?
This review summarizes the available medical evidence regarding the use of drug-eluting stents to overcome restenosis in coronary interventions.
Supports consideration of drug-eluting stents for restenosis; leaves open need for randomized confirmation in coronary disease.
Coronary interventions have revolutionized the treatment of coronary artery disease (CAD). Stents, which were used initially for the complications arising from coronary angiography gradually, came to occupy a more prominent role in coronary interventions. However, restenosis remained a limiting factor from a therapeutic point of view. Recent development of drug-eluting stents is a step toward overcoming this problem. This development has elicited a great interest in both physician as well as patient communities. We have reviewed the available medical evidence regarding drug-eluting stents.
No takes yet. Share an insight, caveat, or question.
Laroia et al. (2003) conducted a review in Coronary artery disease (CAD). Drug-eluting stents was evaluated. A review of available medical evidence indicates that the recent development of drug-eluting stents is a step toward overcoming restenosis in the treatment of coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: